ReviewClinical, cosmetic and investigational dermatology2020
Rhinophyma: Prevalence, Severity, Impact and Management.
Review in Clinical, cosmetic and investigational dermatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 55 citations in OpenAlex.
- Tangential excision of rhinophyma with electrocautery and healing by secondary intention: A case report.JPRAS open · 2026Article
- Innovative Nasal Splitting Technique for Dual Rhinoplasty and Rhinophyma Management: A Case Report and Literature Review.Archives of plastic surgery · 2026Article
- Outcomes of Electrosurgery Combined With 50% TCA Application in Patients With Rhinophyma.Dermatology research and practice · 2026Article
- Risk Factor Analysis Based on Disease Severity: Rosacea Disease Management Strategies and Personalized Recommendations.Journal of cosmetic dermatology · 2026Article
- Fully ablative COSkin health and disease · 2025Article
- Combination of rhinoshave and fractional ablative COJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2025Article
- Efficacy and safety of non-fractional ablative carbon dioxide laser resurfacing for the treatment of rhinophyma - a retrospective cohort and questionnaires-based study.Lasers in medical science · 2025Article
- Social Isolation During COVID-19 Pandemic: Challenges of a Rhinophyma Patient Reluctant to Seek Treatment.Cureus · 2025Article
- Ablative COPlastic and reconstructive surgery. Global open · 2025Article
- The relationship of disease severity with C-reactive protein/albumin ratio and hematological parameters in patients with rosacea.Archives of dermatological research · 2025Article
- Rhinophyma Treatment with Blue Laser.Iranian journal of otorhinolaryngology · 2025Article
- Five-blade scratcher for treating severe rhinophyma: A retrospective study.World journal of clinical cases · 2024Article
- Article
- Rosacea in Older Adults and Pharmacologic Treatments.Drugs & aging · 2024Review
- Optimizing wound healing and cosmesis of surgical closures on rhinophymatous skin.JAAD case reports · 2024Article
- Multiple Foci of Basal Cell Carcinoma Arising in Rhinophyma: A Case Report and Literature Review.JPRAS open · 2023Article
- Radiofrequency electrosurgery of severe, extensive rhinophyma: A case series.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rhinophyma is an advanced stage of rosacea affecting the nasal soft tissues and resulting in disruption of the nasal architecture, airway obstruction, and disfigurement of the nasal aesthetic units. Rhinophyma presents with hypertrophy of the nasal soft tissues, erythema, telangiectasias, nodules, and lobules with a bulbous appearance. Significant psychosocial morbidity is associated with the disease. Understanding of this disease has improved and multiple treatment options exist. The article is a review of the literature to evaluate the pathophysiology, clinical presentation, and epidemiology of keywords "rhinophyma" and "rosacea" using an OVID Medline and PubMed search along with a systematic review of outcomes pertaining to treatment of rhinophyma with laser therapy, scalpel excision, and the subunit method using an OVID Medline search. The subunit method has the highest complication and revision rates followed by carbon dioxide laser therapy. Outcomes between carbon dioxide laser and scalpel therapy and electrocautery are equivalent. Scalpel excision is a more cost-effective treatment modality with less post-operative complications; however, it risks poor hemostasis intraoperatively. Patient satisfaction is common post-therapy regardless of the treatment method. Over 89% of patients would recommend undergoing treatment for rhinophyma irrespective of treatment type. Treatment options vary, and choice of treatment can be dependent on practitioner and patients' treatment goals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.